170 related articles for article (PubMed ID: 10189556)
21. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
Shepherd J
Atheroscler Suppl; 2005 Sep; 6(3):15-9. PubMed ID: 16046280
[TBL] [Abstract][Full Text] [Related]
22. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
23. Diabetic macrovascular disease and serum lipids: is there a connection?
Merrin PK; Feher MD; Elkeles RS
Diabet Med; 1992; 9(1):9-14. PubMed ID: 1551316
[No Abstract] [Full Text] [Related]
24. [Risk factors of microangiopathy in patients with non-insulin dependent diabetes mellitus].
Czech A; Szczeklik Z; Przybyś W
Pol Tyg Lek; 1996 Jan; 51(1-5):35-6. PubMed ID: 8754299
[No Abstract] [Full Text] [Related]
25. [Biochemical research on the lipid spectrum in patients with arteriosclerosis, diabetes and obesity].
Verdonk G; Mortelmans R; Vandevivere D
Brux Med; 1972 Mar; 52(3):165-6. PubMed ID: 5022749
[No Abstract] [Full Text] [Related]
26. Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different age.
Kalofoutis C; Piperi C; Zisaki A; Singh J; Harris F; Phoenix D; Alaveras A; Kalofoutis A
Ann N Y Acad Sci; 2006 Nov; 1084():166-77. PubMed ID: 17151300
[TBL] [Abstract][Full Text] [Related]
27. Coronary risk and dyslipidemia in type 2 diabetic patients.
Udawat H; Goyal RK; Maheshwari S
J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
[TBL] [Abstract][Full Text] [Related]
28. Calculation of coronary risk in Type II diabetes.
Durrington P
Clin Sci (Lond); 2001 Dec; 101(6):681-2. PubMed ID: 11724656
[No Abstract] [Full Text] [Related]
29. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
[TBL] [Abstract][Full Text] [Related]
30. [Immunological aspects of diabetic angiopathies pathogenesis].
Galenok VA; Zhuk EA
Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
[No Abstract] [Full Text] [Related]
31. [Diabetes and dyslipidemia].
Fatati G
Recenti Prog Med; 1999 Jan; 90(1):21-4. PubMed ID: 10193161
[No Abstract] [Full Text] [Related]
32. Cardiovascular prevention in patients with diabetes and prediabetes.
Anselmino M; Gohlke H; Mellbin L; Rydén L
Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
[TBL] [Abstract][Full Text] [Related]
33. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
Boyne MS; Saudek CD
Diabetes Care; 1999 Apr; 22 Suppl 3():C45-53. PubMed ID: 10189562
[TBL] [Abstract][Full Text] [Related]
34. [Dyslipoproteinemia and diabetes mellitus].
Vaverková H
Vnitr Lek; 2000 Sep; 46(9):532-8. PubMed ID: 11344647
[TBL] [Abstract][Full Text] [Related]
35. [Correlation between serum lipids, thrombocyte function and angiopathies in diabetes mellitus].
Duţu A; Gligore V; Hîncu N; Poduţ A; Tecuceanu R
Med Interna (Bucur); 1972 Jan; 24(1):81-8. PubMed ID: 5021765
[No Abstract] [Full Text] [Related]
36. Do people with diabetes need statins?
White JR
Diabetes Educ; 2008; 34(4):664-73. PubMed ID: 18669808
[TBL] [Abstract][Full Text] [Related]
37. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
38. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
Lapotnikov VA; Moiseev SI
Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
[TBL] [Abstract][Full Text] [Related]
39. Postprandial glycemia and cardiovascular disease in diabetes mellitus.
Wajchenberg BL
Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):212-21. PubMed ID: 17505628
[TBL] [Abstract][Full Text] [Related]
40. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
Peter R; Reilly E; Anthony S
Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
